Mjp Associates Inc Gilead Sciences, Inc. Transaction History

Mjp Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 11, 2023	SELL	$76.01 - $86.7 $73,501 - $83,838	-967 Reduced 13.83%	6,023 $464,000
Q1 2023 Apr 17, 2023	BUY	$77.31 - $88.08 $31,851 - $36,288	412 Added 6.26%	6,990 $579,000
Q4 2022 Jan 20, 2023	BUY	$62.32 - $89.47 $53,906 - $77,391	865 Added 15.14%	6,578 $0
Q3 2022 Oct 12, 2022	BUY	$59.54 - $68.01 $46,619 - $53,251	783 Added 15.88%	5,713 $352,000
Q2 2022 Jul 11, 2022	BUY	$57.72 - $65.01 $284,559 - $320,499	4,930 New	4,930 $305,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Mjp Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Mjp Associates Inc with notifications on news.